[乳果糖对8例门腔分流术后慢性肝性脑病患者的双盲研究] - Suppr | 超能文献

[Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].

作者信息

Germain L, Frexinos J, Louis A, Ribet A

出版信息

Arch Fr Mal App Dig. 1973 Jun;62(4):293-302.

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

[Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].[乳果糖对8例门腔分流术后慢性肝性脑病患者的双盲研究]

Arch Fr Mal App Dig. 1973 Jun;62(4):293-302.

2

[Double blind study of lactulose in 8 patients with chronic hepatic encephalopathy after portocaval shunt].[乳果糖对8例门腔分流术后慢性肝性脑病患者的双盲研究]

Arch Fr Mal App Dig. 1973 Jun;62(4):293-302.

3

[Hyperammoniemia and porta-caval encephalopathy in patients with cirrhosis. Personal results of lactulose treatment].[肝硬化患者的高氨血症和门体性脑病。乳果糖治疗的个人结果]

Chir Patol Sper. 1975 Apr;23(2):77-95.

4

Lactulose in the treatment of chronic portal-systemic encephalopathy. A double-blind clinical trial.乳果糖治疗慢性门体性脑病。一项双盲临床试验。

N Engl J Med. 1969 Aug 21;281(8):408-12. doi: 10.1056/NEJM196908212810803.

5

[Lactulose in the treatment of portacaval encephalopathy].

Clin Ter. 1971 Oct 15;59(1):59-67.

6

[Correction by L-dopa of neurologic manifestations of a chronic portocaval encephalopathy].[左旋多巴对慢性门腔静脉性脑病神经症状的纠正作用]

Rev Neurol (Paris). 1972 Nov;127(5):560-3.

7

[Therapeutic effect of lactulose on shunt encephalopathy and blood ammonia concentration in cirrhosis patients].

Fortschr Med. 1972 Aug 31;90(24):837-48.

8

[Lactulose in the therapy of porto-systemic encephalopathy].

Minerva Med. 1973 Dec 5;64(87):4596-603.

9

Comparison of lactulose and neomycin in the treatment of chronic portal-systemic encephalopathy. A double blind controlled trial.乳果糖与新霉素治疗慢性门体性脑病的比较。一项双盲对照试验。

Gastroenterology. 1977 Apr;72(4 Pt 1):573-83.

10

Some observations on the effects of treatment with lactulose on patients with chronic hepatic encephalopathy.关于乳果糖治疗慢性肝性脑病患者效果的一些观察

Q J Med. 1970 Apr;39(154):245-63.

引用本文的文献

1

Non-absorbable disaccharides versus placebo/no intervention and lactulose versus lactitol for the prevention and treatment of hepatic encephalopathy in people with cirrhosis.不可吸收双糖与安慰剂/无干预措施的比较以及乳果糖与乳糖醇在肝硬化患者肝性脑病预防和治疗中的比较。

Cochrane Database Syst Rev. 2016 May 6;2016(5):CD003044. doi: 10.1002/14651858.CD003044.pub4.

2

Lactulose, rifaximin or branched chain amino acids for hepatic encephalopathy: what is the evidence?乳果糖、利福昔明或支链氨基酸治疗肝性脑病：有何证据？

Metab Brain Dis. 2013 Jun;28(2):221-5. doi: 10.1007/s11011-012-9372-0. Epub 2012 Dec 29.

3

Neomycin-sorbitol and lactulose in the treatment of acute portal-systemic encephalopathy. A controlled, double-blind clinical trial.新霉素-山梨醇和乳果糖治疗急性门体性脑病：一项对照双盲临床试验

Am J Dig Dis. 1978 May;23(5):398-406. doi: 10.1007/BF01072921.